Tudor Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
1,047
+12
+1% +$12.3K 0.56% 54
2026
Q1
$952K Buy
1,035
+5
+0.5% +$5.07K 0.49% 65
2025
Q4
$1.11M Sell
1,030
-54
-5% -$51.6K 0.57% 51
2025
Q3
$827K Buy
1,084
+5
+0.5% +$3.72K 0.44% 64
2025
Q2
$841K Sell
1,079
-8
-0.7% -$6.22K 0.48% 59
2025
Q1
$898K Buy
1,087
+1
+0.1% +$832 0.54% 54
2024
Q4
$839K Buy
1,086
+634
+140% +$525K 0.49% 61
2024
Q3
$400K Buy
+452
New +$406K 0.25% 98

Other funds holding LLY

Tudor Financial's LLY Position: Q2 2026 in Review

Tudor Financial increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $12.3K and bringing the position to 1,047 shares worth $1.26M. The position accounts for 0.56% of the portfolio, ranked #54.

Tudor Financial first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tudor Financial held 1,047 shares of Eli Lilly worth $1.26M as of Q2 2026.
  • Tudor Financial bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.56% of Tudor Financial's portfolio in Q2 2026, its #54 holding.
  • Tudor Financial first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tudor Financial's 13F filing for Q2 2026, filed 6 Aug 2026.